-
公开(公告)号:CA2388859A1
公开(公告)日:2001-04-26
申请号:CA2388859
申请日:2000-10-10
Applicant: ABBOTT LAB
Inventor: MARING CLARENCE J , WAGENAAR FRANK L , WANG SHELDON , GIRANDA VINCENT L , LIN ZHEN , FLOSI WILLIAM J , DEGOEY DAVID A , KLEIN LARRY L , KEMPF DALE J , STOLL VINCENT S , KATI WARREN M , GRAMPOVNIK DAVID J , KENNEDY APRIL L , WIEDEMAN PAUL E , MCDANIEL KEITH F , TU NOAH P , XU YIBO , HANESSIAN STEPHEN , STEWART KENT D , SHAM HING L , MUCHMORE STEVEN W , WANG GARY T , BAYRAKDARIAN MALKEN , LUO XUEHONG , CHEN YUANWEI , MADIGAN DAROLD L , YEUNG MING C , ZHAO CHEN , KRUEGER ALLAN C , GU YU GUI , CHEN HUI-JU , SUN MINGHUA
IPC: C07D401/12 , A61K31/357 , A61K31/40 , A61K31/401 , A61K31/4025 , A61K31/405 , A61K31/415 , A61K31/4155 , A61K31/4178 , A61K31/42 , A61K31/422 , A61K31/425 , A61K31/427 , A61K31/4439 , A61K31/5377 , A61K31/66 , A61K31/662 , A61P31/00 , A61P31/12 , A61P31/16 , A61P43/00 , C07D20060101 , C07D207/00 , C07D207/12 , C07D207/16 , C07D207/26 , C07D207/32 , C07D207/327 , C07D207/38 , C07D207/46 , C07D303/16 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D407/06 , C07D407/12 , C07D409/06 , C07D413/04 , C07D413/06 , C07D417/04 , C07D417/06 , C07D521/00 , C07F9/40 , C07F9/572
Abstract: Enantiomerically enriched compounds having the absolute stereochemistry of t he formula (I) or a pharmaceutically acceptable salt, ester or prodrug thereof, which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caused by microorganisms having a neuraminidase, processes for preparing the compounds and synthetic intermediates used in these processes.
-
公开(公告)号:CZ20003872A3
公开(公告)日:2001-03-14
申请号:CZ20003872
申请日:1999-04-12
Applicant: ABBOTT LAB
Inventor: MARING CLARENCE J , GU YU-GUI , CHEN HUI-YU , CHEN YUANWEI , DEGOEY DAVID A , FLOSI WILLIAM J , GIRANDA VINCENT L , GRAMPOVNIK DAVID J , KATI WARREN M , KEMPF DALE J , KLEIN LARRY L , KRUEGER ALLAN C , LIN ZHEN , MADIGAN DAROLD L , MCDANIEL KEITH F , MUCHMORE STEVEN W , SHAM HING L , STEWART KENT D , STOLL VINCENT S , SUN MINGHUA , WANG GARY T , WANG SHELDON , XU YIBO , YEUNG MING C , ZHAO CHEN , KENNEDY APRIL
IPC: A61K31/40 , A61P31/16 , C07D207/16 , C07D401/12 , C07D403/04 , C07D407/04 , C07D409/04 , C07D413/04 , C07D417/04
-
公开(公告)号:CA2329660A1
公开(公告)日:1999-10-28
申请号:CA2329660
申请日:1999-04-12
Applicant: ABBOTT LAB
Inventor: DEGOEY DAVID A , SUN MINGHUA , SHAM HING L , ZHAO CHEN , CHEN YUANWEI , WANG GARY T , GIRANDA VINCENT L , GRAMPOVNIK DAVID J , KENNEDY APRIL , YEUNG MING , MUCHMORE STEVEN W , MADIGAN DAROLD L , LIN ZHEN , STEWART KENT D , GU YU-GUI , WANG SHELDON , STOLL VINCENT S , MARING CLARENCE J , KEMPF DALE J , KATI WARREN M
IPC: A61K31/196 , A61K31/215 , A61K31/341 , A61K31/4164 , A61K31/421 , A61P31/16 , A61P43/00 , C07C233/47 , C07C233/52 , C07C237/24 , C07C271/22 , C07C271/24 , C07D233/54 , C07D263/32 , C07D307/24 , C07D317/32 , C07D405/04 , C07D493/08 , A61K31/16 , A61K31/33
Abstract: Disclosed are compounds of formula (I), (II) or (III), which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caused by microorganisms having a neuraminidase, processes for preparing the compounds and synthetic intermediates used in these processes.
-
54.
公开(公告)号:CA2744711C
公开(公告)日:2017-06-27
申请号:CA2744711
申请日:2009-12-04
Applicant: ABBOTT LAB
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D
IPC: C07D405/12 , A61K31/404 , A61P35/00 , C07D209/32 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D235/26 , C07D249/04 , C07D295/125 , C07D295/14 , C07D309/14 , C07D401/12
Abstract: Disclosed are compounds of formula (I) which inhibit the activity of anti-apoptotic BcI -2 or BcI -xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti -aooptotic Bcl-2 protein.
-
公开(公告)号:BRPI1014359A2
公开(公告)日:2016-04-05
申请号:BRPI1014359
申请日:2010-05-26
Applicant: ABBOTT LAB
Inventor: KUNZER AARON R , SOUERS ANDREW J , WANG GARY T , DOHERTY GEORGE , SULLIVAN GERARD , DING HONG , HEXAMER LAURA , WANG LE , HASVOLD LISA , WENDT MICHAEL , BRUNCKO MILAN , MANTEI ROBERT , ELMORE STEVEN , HANSEN TODD M , SONG XIAOHONG , WANG XILU , TAO ZHIFU
IPC: C07D471/04 , A61K31/437 , A61P35/00
-
56.
公开(公告)号:ZA201208832B
公开(公告)日:2013-07-31
申请号:ZA201208832
申请日:2012-11-22
Applicant: ABBOTT LAB
Inventor: BRUNCKO MILAN , DOHERTY GEORGE , HASVOLD LISA , KUNZER AARON R , SOUERS ANDREW J , TAO ZHI-FU , WANG LE , WENDT MICHAEL , HANSEN TODD M , DING HONG , ELMORE STEVEN , HEXAMER LAURA , SONG XIAOHONG , SULLIVAN GERARD , WANG GARY T , WANG XILU , MANTEI ROBERT
IPC: A61K20060101 , C07D20060101
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
-
公开(公告)号:CR20120346A
公开(公告)日:2012-09-03
申请号:CR20120346
申请日:2012-06-25
Applicant: ABBOTT LAB
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PETROS ANDREW M , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D , HANSEN TODD M , SONG XIAOHONG , PARK CHANG H , PARK CHEOL-MIN
IPC: C07D405/12 , A61K31/404 , A61P35/00 , C07D209/32 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D231/56 , C07D235/26 , C07D249/04 , C07D295/125 , C07D295/14 , C07D309/14 , C07D401/12 , C07D405/14
Abstract: Compuestos que inhiben la actividad de las proteínas anti-apoptóticas Bcl-2 o Bcl-XL, composiciones que contienen dichos compuestos y métodos para tratar enfermedades durante las cuales se expresa la proteína anti-apoptótica Bcl-2.
-
58.
公开(公告)号:MX2012006391A
公开(公告)日:2012-06-19
申请号:MX2012006391
申请日:2010-06-01
Applicant: ABBOTT LAB
Inventor: WANG GARY T , HEXAMER LAURA , SULLIVAN GERARD M , WANG LE , TAO ZHI-FU , BRUNCKO MILAN , WENDT MICHAEL D , DAI YUJIA , DING HONG , ELMORE STEVEN W , MCCELLAN WILLIAM J , HANSEN TODD M , SOUERS ANDREW J , SONG XIAOHONG , PARK CHEOL-MIN , MANTEI ROBERT A , DOHERTY GEORGE A , HASVOLD LISA , PARK CHANG H , PETROS ANDREW M , KUNZER AARON
IPC: C07D209/08 , C07D211/58 , C07D213/74 , C07D213/84 , C07D231/56 , C07D235/06 , C07D277/24 , C07D309/04 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12 , C07D417/12 , C07D471/04
Abstract: Se describen los compuestos que inhiben la actividad de las proteínas anti-apoptóticas BcI-2, las composiciones que contienen los compuestos, y los métodos para tratar las enfermedades durante las cuales se expresa la proteína anti-apoptótica Bcl-2.
-
59.
公开(公告)号:MX2012005162A
公开(公告)日:2012-06-01
申请号:MX2012005162
申请日:2010-10-18
Applicant: ABBOTT LAB
Inventor: ERICKSON SCOTT A , KAWAI MEGUMI , SHEPPARD GEORGE S , FIDANZE STEVE D , WANG GARY T , CLARK RICHARD F , MANTEI ROBERT A , BA-MAUNG NWE Y , SORENSON BRYAN K
IPC: C07D471/04 , A61K31/437 , A61P35/00
Abstract: Se describen los compuestos que inhiben las proteínas cinasas, las composiciones que contienen los compuestos y los métodos para tratar las enfermedades al usar los compuestos de fórmula (I).
-
公开(公告)号:MX2011012632A
公开(公告)日:2012-03-06
申请号:MX2011012632
申请日:2010-05-26
Applicant: ABBOTT LAB
Inventor: ERICKSON SCOTT A , SHEPPARD GEORGE S , WANG JIEYI , FIDANZE STEVE D , WANG GARY T , BELL RANDY L , MANTEI ROBERT A
IPC: A61K31/506 , C07D401/14 , A61K35/00 , C07D403/12 , C07D403/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
Abstract: En la presente solicitud se describen compuestos de la fórmula (I) o sales o solvatos farmacéuticamente aceptables de los mismos, en la cual L1, R2, R3, R4, R5, y m se definen en la descripción. También se describen métodos para elaborar dichos compuestos, y composiciones que comprenden dichos compuestos los cuales son útiles para inhibir cinasas tales como IGF-IR.
-
-
-
-
-
-
-
-
-